# Innobiosurg Co., Ltd.

- Location (FDA's records): Daejeon, KR
- FDA decisions: 15 (2015–2022): 15 510(k) clearances
- Product codes: DZE (10), NHA (5)
- 510(k) review time since 2016: median 156 days, against 219 for FDA's reviews in the same codes and years (10 of 14 faster)
- Predicates its devices cite: 28 (20 its own); citations of its devices by later devices: 21 (20 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Osstem Implant Co., Ltd.: 3 (https://510kreport.com/company/osstem-implant)
- Dentis Co., Ltd.: 2 (https://510kreport.com/company/dentis)
- Neobiotech Co., Ltd.: 1 (https://510kreport.com/company/neobiotech)
- Dio Corporation: 1 (https://510kreport.com/company/dio)
- Csm Implant: 1 (https://510kreport.com/company/csm-implant)

## Firms that cite its devices most
- Cowellmedi Co., Ltd.: 1 (https://510kreport.com/company/cowellmedi)

## Its most-cited devices
- K140806: Ibs Implant System (2015), cited by 3
- K153350: IBS Implant System (2016), cited by 3
- K173120: CCM Abutment System (2018), cited by 3
- K192197: Magicore II System (2020), cited by 2
- K152520: Magicore System (2016), cited by 2
- K201981: Magicore System (2020), cited by 2

## Recent decisions
- K220517: IBS System (Dec 20, 2022)
- K220079: Magicore Narrow System (Dec 14, 2022)
- K212517: Magicore System (Oct 15, 2021)
- K203344: Premilled Titanium Block System (Aug 25, 2021)
- K202418: Magic UCLA Abutment System (Dec 3, 2020)
- K202479: IBS Implant System (Sep 23, 2020)
- K201981: Magicore System (Aug 27, 2020)
- K201621: Magicore II System (Jul 15, 2020)

Source page: https://510kreport.com/company/innobiosurg